SMALL HUMAN STUDIES · TWO DIFFERENT FORMS
CJC-1295: Two forms, short studies, and open health questions
CJC-1295 prompts growth hormone release. Read about its forms and pairing with ipamorelin, a separate compound that also prompts growth hormone release.

CJC-1295 Raised Blood-Test Levels in Healthy Adults
A peptide such as CJC-1295 has protein parts joined in a short chain. Here you'll learn what its forms and small studies mean for your questions.
The human studies were brief and tested healthy adults, leaving benefits for patients uncertain. After one shot beneath the skin, growth hormone rose 2- to 10-fold and was still raised at least six days later [1].
A hormone carries messages through blood, and growth hormone helps direct growth. The rise in another hormone that the liver makes lasted nine to eleven days.
DAC, an added part on the longer-lasting form, attaches to a blood protein [3]. Both forms also have four changed amino acids, the parts joined together to form proteins.
Those four changes help both forms resist being broken down by the body. The separate DAC addition makes the longer-lasting form remain in blood about 250-fold longer.
You'll need to know which form a study used before comparing findings [14]. Longer time in blood doesn't establish more benefit for your health.
Teichman (2006) and Ionescu and Frohman (2006) studied 24 healthy adults between them. The longest follow-up was 49 days; volunteers and staff didn't know who got CJC-1295 or a placebo, a shot without the compound [1][2].
The form without DAC hasn't had its time in blood measured in published human testing. Mod GRF 1-29 is another name for that shorter-lasting form.
One study used mice unable to make the hormone prompting growth hormone release. After daily CJC-1295 shots for five weeks, their weight, bone length, and signs of growth hormone production reached normal levels [4].
Those lab signs showed the mice's cells making the material needed to produce growth hormone. I'd ask your doctor whether findings in healthy adults or mice answer your health question, how any benefit would be checked, and what follow-up would involve for your time and costs.
CJC-1295 Health Claims Go Beyond the Hormone Findings
The CJC-1295 studies mainly measured hormones, leaving changes you could feel unproved. A higher blood-test result doesn't tell you that lifting or walking would become easier.
Healthy adults in the Teichman 2006 trial received CJC-1295 at amounts of 30, 60, 90, and 125 micrograms per kilogram, based on weight. A microgram is one of a million equal parts of a gram; the growth hormone rise was 2- to 10-fold [1].
The liver's growth-related hormone also stayed raised, with the rise lasting nine to eleven days. Larger study amounts caused larger rises, but don't establish an amount suited to your own health.
Ionescu and Frohman 2006 studied the gland beneath the brain that makes growth hormone. The average hormone level rose 46%, while the usual bursts kept their timing and size [2].
CJC-1295 prompts production, while growth hormone shots can tell that gland to make less of its own hormone. That's the body's way of limiting extra production when enough hormone is already present.
Studies of tesamorelin, a different compound that prompts growth hormone release, involved people with HIV-associated fat buildup, linked to a virus that weakens the immune system. Those patients had excess fat around belly organs; deep belly fat fell at six months and about 18% by twelve months [9].
The 2026 review covered tesamorelin studies in people with that same fat problem [21]. The review found less belly and liver fat and reassuring safety results for tesamorelin during testing.
Those studies didn't test CJC-1295, so you can't expect the same results from it. Nor do short safety findings settle problems that might emerge after years.
Ipamorelin is a separate compound that also prompts growth hormone release. In rats given steroids that slowed bone growth, outer bone growth was four times greater with ipamorelin than with the steroid alone [10].
Another rat study lasted seven days and used prednisolone, a steroid medicine that caused protein loss. With ipamorelin, tests showed the rats kept more protein, about as much as rats given growth hormone [11].
Keeping protein isn't the same as proving stronger muscles in people. You can explore the reasons for pairing compounds on the CJC-1295 and ipamorelin page, while keeping those limits in mind.
CJC-1295 Is a Peptide and Lacks FDA Approval
As a peptide, CJC-1295 consists of small parts joined into a short chain. A steroid has a different structure and action; these aren't names for the same medicine.
The compound prompts the gland beneath your brain to make and release growth hormone [12]. The compound works on that gland's growth hormone cells, without directly acting on sex hormone cells.
That distinction explains the compound’s action, but doesn't establish safety for you. Ask your doctor what benefit has been measured for the concern you're bringing.
The FDA, the agency that approves medicines, hasn't approved this compound for any use. In December 2024, an FDA panel considered its use in medicines pharmacies mix for individual patients [16].
The agency raised concerns about clumps and unwanted material in those shots. Such material may trigger your immune system, the body's defense against germs and other threats.
WADA, the body that sets banned drug rules in sport, prohibits CJC-1295. A study's hormone findings can't settle approval or the risks of a proposed shot.
CJC-1295 Can Also Lead Your Kidneys to Keep Water
CJC-1295 prompts growth hormone release, but blood tests alone don't show a health benefit. The form tested matters because one lasts longer than the other.
Halmos and colleagues reviewed the gland's response in 2025 [12]. Growth hormone cells both release stored hormone and make more after the compound reaches them.
Your liver responds to growth hormone by making another growth-related hormone. Your kidneys may also keep more salt, and water stays with that salt [8].
That water can help explain swelling seen with larger study amounts [13]. You can ask how your doctor would check swelling and decide whether another visit is needed.
A question for your visit is whether any measured change would help your daily life. The CJC-1295 study amounts and CJC-1295 side effects pages explain what researchers measured and what remains unknown.